Mutation analyses of Uroplakin II in children with renal tract malformations
Author(s) -
Dagan Jenkins,
Maria BitnerGlindzicz,
S Malcolm,
Jennifer Allison,
Rose de Bruyn,
Sarah E. Flanagan,
D.F.M. Thomas,
Rachel Belk,
Sally Feather,
Coralie Bingham,
Jennifer Southgate,
Adrian S. Woolf
Publication year - 2006
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfl465
Subject(s) - hydronephrosis , renal pelvis , medicine , urothelium , urinary system , pathology , kidney , ureter , frameshift mutation , pathogenesis , nephropathy , mutation , biology , genetics , urology , endocrinology , gene , diabetes mellitus
Uroplakin (UP) proteins cover urothelial apical surfaces. Mice lacking UPIIIa have elevated urothelial permeability and congenital renal tract anomalies, and UPIIIa mutations have been reported in children with kidney and ureter malformations. Mice with null mutation of another UP family member, UPII, are often born with congenital hydronephrosis. We hypothesized that UPII mutations may be present in humans with renal tract malformations.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom